Alexandra Investment Management

Alexandra Investment Management is a New York-based hedge fund and investment management firm founded in 1999 by Mikhail Petkevich. The firm historically specialized in convertible arbitrage and was a prolific provider of Private Investment in Public Equity (PIPE) financing to small-cap and micro-cap companies, with a significant focus on the biotechnology and healthcare sectors. During the early 2000s, it was one of the most active institutional investors in the life sciences space, providing critical growth capital to emerging drug development companies. The firm is not a biotechnology company itself and does not possess a clinical pipeline or proprietary therapeutic platforms. Its market presence significantly diminished following the 2008 financial crisis, and it is currently considered inactive in the primary biotech investment landscape.